Green light for £60m Citylabs campus expansion
MANCHESTER City Council has approved plans for a £60m investment in a two-phase expansion of its Citylabs biomedical campus.
Read moreResearch and innovation news
Keep up-to-date with the latest news, publications and events from the Research and Innovation team at MFT.
What research can I access at Manchester Vascular Centre?
Our ultimate aim is to offer patients with any vascular condition the chance to participate in a research study or clinical trial that will directly benefit them.
Read more
New collaborative Greater Manchester study on the impact of major trauma
A new collaborative across Greater Manchester is to carry out a cutting-edge study to improve clinical outcomes for patients admitted to hospital with major trauma.
Read more
Parent-mediated therapy may help babies at risk of developing autism
This study is the first of its kind to work with babies in their first year of life who have a sibling with autism and are therefore at higher risk of developing the condition.
Read more
A new era in precision medicine for pancreatic cancer
Dr Derek O'Reilly blogs about an important investment by Cancer Research UK into pancreatic cancer research and how CMFT is involved in this work.
Read more
Call for Wearable and Sensor technology proposals in new £50,000 innovation funding round
Applications are open for Central Manchester University Hospitals NHS Foundation Trust (CMFT) staff to access a £50,000 fund to develop Wearable technology for clinical use.
Read more
Research Programme Managers’ Network
The RPMN is a peer support network where central issues in research grant management are discussed, and as a collective, members can make a meaningful contribution to research innovation.
Read more
Research shows effective communication from doctors could reduce anxiety for wet age-related macular degeneration patients
The study, authored by Dr Tariq Aslam, demonstrates the value of interaction between clinician and patient in offering reassurance around the efficacy and safety associated with anti-VEGF injections.
Read more
